Home > Balance Sheet > BETA DRUGS

BETA DRUGS
Net Current Assets

    Back to Balance Sheet
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Net Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Current Assets (Including Current Investments) ₹227 Cr₹218 Cr₹93 Cr₹65 Cr₹48 Cr

What is the latest Net Current Assets ratio of BETA DRUGS ?

The latest Net Current Assets ratio of BETA DRUGS is ₹227 Cr based on Mar2026 Consolidated results.
Year Net Current Assets
Mar2026₹227 Cr
Mar2025₹218 Cr
Mar2024₹93 Cr
Mar2023₹65 Cr
Mar2022₹48 Cr

How is Net Current Assets of BETA DRUGS Trending?

Years Net Current Assets % Change
Mar2026 ₹227 Cr
4.30
Mar2025 ₹218 Cr
133.54
Mar2024 ₹93 Cr
44.12
Mar2023 ₹65 Cr
34.76
Mar2022 ₹48 Cr -

Compare Net Current Assets of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,004.5 Cr 1.7% -9.3% -0.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,276.0 Cr 5.2% 4.3% 8% Stock Analytics
DIVIS LABORATORIES ₹273,565.0 Cr 3.6% 7.6% 50.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹180,332.0 Cr 3.4% 0.7% 32.6% Stock Analytics
DR REDDYS LABORATORIES ₹114,532.0 Cr 2.3% 14% 13.6% Stock Analytics
CIPLA ₹113,831.0 Cr 2% 6% -6.7% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

1.7%

-9.3%

-0.8%

SENSEX

8.8%

10.9%

-4%


You may also like the below Video Courses